Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) EBT (2017 - 2025)

Historic EBT for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to -$2.3 million.

  • Catheter Precision's EBT rose 4500.0% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.9 million, marking a year-over-year decrease of 3634.03%. This contributed to the annual value of -$13.5 million for FY2024, which is 8086.78% up from last year.
  • Catheter Precision's EBT amounted to -$2.3 million in Q3 2025, which was up 4500.0% from -$6.4 million recorded in Q2 2025.
  • Catheter Precision's 5-year EBT high stood at -$669000.0 for Q4 2023, and its period low was -$66.4 million during Q1 2023.
  • Moreover, its 5-year median value for EBT was -$4.8 million (2022), whereas its average is -$8.0 million.
  • In the last 5 years, Catheter Precision's EBT crashed by 110837.12% in 2023 and then skyrocketed by 9597.14% in 2024.
  • Quarter analysis of 5 years shows Catheter Precision's EBT stood at -$8.3 million in 2021, then rose by 1.53% to -$8.2 million in 2022, then surged by 91.8% to -$669000.0 in 2023, then plummeted by 271.75% to -$2.5 million in 2024, then grew by 8.89% to -$2.3 million in 2025.
  • Its EBT was -$2.3 million in Q3 2025, compared to -$6.4 million in Q2 2025 and -$4.8 million in Q1 2025.